Risk Factors and Anticoagulation Therapy in Patients With Isolated Distal Deep Vein Thrombosis in the Early Post-operative Period After Thoracic Surgery
- PMID: 33996889
- PMCID: PMC8113622
- DOI: 10.3389/fsurg.2021.671165
Risk Factors and Anticoagulation Therapy in Patients With Isolated Distal Deep Vein Thrombosis in the Early Post-operative Period After Thoracic Surgery
Abstract
Background: Isolated distal deep vein thrombosis (IDDVT) accounts for ~50% of all patients diagnosed with deep venous thrombosis (DVT), but the diagnosis and optimal management of IDDVT remains unclear and controversial. The aim of this study was to explore potential risk factors and predictors of IDDVT, and to evaluate different strategies of anticoagulation therapy. Methods: A total of 310 consecutive patients after thoracic surgery, who underwent whole-leg ultrasonography as well as routine measurements of D-dimer levels before and after surgery were evaluated. The general clinical data, anticoagulant therapy, pre- and postoperative D-dimer levels were collected. Differences between IDDVT, DVT and non-DVT groups were calculated. Logistic regression analysis was used to analyze risk factors of postoperative IDDVT. Results: Age and postoperative D-dimer levels were significantly higher in IDDVT group than in non DVT group (p = 0.0053 and p < 0.001, respectively). Logistic regression analysis showed that postoperative D-dimer level was a significant independent predictor of IDDVT even when adjusted for age and operation method (p = 0.0003). There were no significant side effects associated with both full-dose and half-dose anticoagulation regimens. Half-dose therapy was associated with a significant decrease in the requirement for anticoagulation medications after discharge (p = 0.0002). Conclusion: Age and D-dimer levels after surgery are strong predictors of IDDVT following thoracic surgery. Half-dose therapeutic anticoagulation has the same efficiency in preventing IDDVT progression, is not associated with any additional risks of adverse effects compared to a full-dose regimen, and may be adopted for treating IDDVT patients after thoracic surgery.
Keywords: D-dimer; IDDVT; anticoagulation therapy; risk factors; thoracic surgery.
Copyright © 2021 Li, Ding, Shen, Yang, Wang, Zhou, Jiang, Zhu and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
[The predictive value of dynamic changes of coagulation function for the occurrence and progression of isolated distal deep vein thrombosis of lower limbs in patients with acute brain injury].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Jun;33(6):721-726. doi: 10.3760/cma.j.cn121430-20210323-00427. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34296693 Chinese.
-
Hospitalized patients with isolated distal deep vein thrombosis: anticoagulation therapy or not?Thromb J. 2022 Sep 13;20(1):52. doi: 10.1186/s12959-022-00410-1. Thromb J. 2022. PMID: 36100922 Free PMC article.
-
Retrospective review of D-dimer testing for venous thrombosis recurrence risk stratification: is this a useful test in the real world?J Thromb Thrombolysis. 2020 May;49(4):562-571. doi: 10.1007/s11239-020-02101-y. J Thromb Thrombolysis. 2020. PMID: 32253709
-
How to treat isolated distal deep vein thrombosis.Pol Arch Intern Med. 2023 Aug 30;133(7-8):16543. doi: 10.20452/pamw.16543. Epub 2023 Aug 7. Pol Arch Intern Med. 2023. PMID: 37548526 Review.
-
Significance and management of isolated distal deep vein thrombosis.Curr Opin Hematol. 2021 Sep 1;28(5):331-338. doi: 10.1097/MOH.0000000000000670. Curr Opin Hematol. 2021. PMID: 34267078 Review.
Cited by
-
Generation of a Predictive Clinical Model for Isolated Distal Deep Vein Thrombosis (ICMVT) Detection.Med Sci Monit. 2023 Dec 31;29:e942840. doi: 10.12659/MSM.942840. Med Sci Monit. 2023. PMID: 38160251 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources